DS
CHTP

DRW Securities’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

DRW Securities’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-80,012
Closed -$236K – 284
2013
Q3 		$236K Buy
+80,012
New +$230K 0.02% 131

Other funds holding CHTP

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DRW Securities's CHTP Position: Q4 2013 in Review

DRW Securities sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q4 2013, closing a stake of 80,012 shares — an estimated $236K sold.

DRW Securities first reported a position in CHTP in Q3 2013 and held it in 1 quarter. The position peaked at $236K in Q3 2013. 78 funds tracked by Wall St. Rank hold CHTP as of Q4 2013.

  • DRW Securities reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q4 2013 after selling out during the quarter.
  • DRW Securities sold 80,012 CHELSEA THERAPEUTICS INT'L LTD shares in Q4 2013, an estimated $236K.
  • DRW Securities first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q3 2013 and held it in 1 quarter.
  • DRW Securities's CHELSEA THERAPEUTICS INT'L LTD position peaked at $236K in Q3 2013.
  • 78 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q4 2013.

Based on DRW Securities's 13F filing for Q4 2013, filed 14 Feb 2014.